Metraipolis › archive › dc_fea90d005f21

Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42278363
DOI
10.3390/ijms27114832
License (as archived)
solo-consultazione
Archived
2026-11-01T05:56:53.894Z
SHA-256 of the archived text
54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d
Stable URL of this page
https://metraipolis.com/documento/dc_fea90d005f21

How to cite

Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363 — Europe PMC (en), https://europepmc.org/article/MED/42278363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea90d005f21 (Metraipolis archive dc_fea90d005f21, sha256 54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d)
BibTeX
@misc{dcfea90d005f21,
  title = {Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42278363},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea90d005f21; sha256 54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278363. Agents can read the archived copy with the MCP tool read_document.